Deep Track Capital, LP 13F holdings
Deep Track Capital, LP reported 66 positions with a total reported value of $6.8B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: GH GUARDANT HEALTH INC (7.5%), IMVT IMMUNOVANT INC (5.3%), GPCR STRUCTURE THERAPEUTICS INC (3.7%), PCVX VAXCYTE INC (3.7%), ALNY ALNYLAM PHARMACEUTICALS INC (3.7%). Against 2026-03-31 it opened 18 new positions and exited 14. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Deep Track Capital, LP files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 66 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| GH GUARDANT HEALTH INC | 3,393,312 | $509.1M | 7.5% |
| IMVT IMMUNOVANT INC | 9,341,151 | $359.9M | 5.3% |
| GPCR STRUCTURE THERAPEUTICS INC | 4,740,072 | $254.4M | 3.7% |
| PCVX VAXCYTE INC | 4,300,000 | $250.0M | 3.7% |
| ALNY ALNYLAM PHARMACEUTICALS INC | 825,000 | $248.3M | 3.7% |
| MANE VERADERMICS INC | 2,000,000 | $245.9M | 3.6% |
| TARS TARSUS PHARMACEUTICALS INC | 3,666,768 | $230.8M | 3.4% |
| NUVL NUVALENT INC | 1,783,322 | $220.2M | 3.2% |
| ALKS ALKERMES PLC | 4,000,000 | $209.6M | 3.1% |
| OCUL OCULAR THERAPEUTIX INC | 19,686,282 | $193.3M | 2.8% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 3,307,481 | $189.3M | 2.8% |
| NRIX NURIX THERAPEUTICS INC | 7,736,455 | $187.7M | 2.8% |
| ORKA ORUKA THERAPEUTICS INC | 1,926,000 | $183.3M | 2.7% |
| ALMS ALUMIS INC | 6,348,558 | $178.6M | 2.6% |
| IONS IONIS PHARMACEUTICALS INC | 2,200,000 | $174.4M | 2.6% |
| CMPS COMPASS PATHWAYS PLC | 12,161,496 | $172.1M | 2.5% |
| VERA VERA THERAPEUTICS INC | 4,000,000 | $171.6M | 2.5% |
| AXSM AXSOME THERAPEUTICS INC. | 700,000 | $171.3M | 2.5% |
| GMAB GENMAB A/S | 5,650,000 | $155.2M | 2.3% |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | 6,999,025 | $136.3M | 2.0% |
| COAG HEMAB THERAPEUTICS HLDGS INC | 3,602,093 | $132.3M | 1.9% |
| TNGX TANGO THERAPEUTICS INC | 4,200,000 | $131.3M | 1.9% |
| DFTX DEFINIUM THERAPEUTICS INC | 2,750,000 | $129.4M | 1.9% |
| GRAL GRAIL INC | 1,834,944 | $125.3M | 1.8% |
| BCAX BICARA THERAPEUTICS INC | 4,100,000 | $121.7M | 1.8% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 18 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ALNY ALNYLAM PHARMACEUTICALS INC | 825,000 | $248.3M | 3.7% |
| COAG HEMAB THERAPEUTICS HLDGS INC | 3,602,093 | $132.3M | 1.9% |
| GHRS GH RESEARCH PLC | 3,333,334 | $89.6M | 1.3% |
| UTHR UNITED THERAPEUTICS CORP DEL | 123,616 | $67.0M | 1.0% |
| AVTX AVALO THERAPEUTICS INC | 3,610,000 | $66.7M | 1.0% |
| ALT ALTIMMUNE INC | 19,250,000 | $58.5M | 0.9% |
| WGS GENEDX HOLDINGS CORP | 700,000 | $48.1M | 0.7% |
| HROW HARROW INC | 969,000 | $41.2M | 0.6% |
| IMMX IMMIX BIOPHARMA INC | 2,775,000 | $28.6M | 0.4% |
| STTK SHATTUCK LABS INC | 3,706,734 | $25.7M | 0.4% |
| MNKD MANNKIND CORP | 6,000,000 | $25.6M | 0.4% |
| GENB GENERATE BIOMEDICINES INC | 1,333,815 | $22.5M | 0.3% |
| NKTR NEKTAR THERAPEUTICS | 300,000 | $20.9M | 0.3% |
| OLMA OLEMA PHARMACEUTICALS INC | 1,500,000 | $18.8M | 0.3% |
| KLRA KAILERA THERAPEUTICS INC | 700,000 | $15.4M | 0.2% |
| KARD KARDIGAN INC | 600,000 | $14.3M | 0.2% |
| ELVN ENLIVEN THERAPEUTICS INC | 225,000 | $11.4M | 0.2% |
| XNCR XENCOR INC | 593,551 | $9.6M | 0.1% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 14 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 4,532,374 | $182.3M | 3.8% |
| CENTESSA PHARMACEUTICALS PLC | 3,158,041 | $125.4M | 2.6% |
| BBIO BRIDGEBIO PHARMA INC | 841,445 | $62.5M | 1.3% |
| TERNS PHARMACEUTICALS INC | 1,073,877 | $56.6M | 1.2% |
| GERN GERON CORP | 31,720,278 | $47.3M | 1.0% |
| ANIP ANI PHARMACEUTICALS INC | 600,000 | $46.1M | 1.0% |
| SOLENO THERAPEUTICS INC | 1,078,710 | $36.1M | 0.7% |
| ENGN ENGENE HOLDINGS INC | 4,377,572 | $29.8M | 0.6% |
| APGE APOGEE THERAPEUTICS INC | 285,000 | $24.0M | 0.5% |
| JANX JANUX THERAPEUTICS INC | 1,187,290 | $16.5M | 0.3% |
| CBIO CRESCENT BIOPHARMA INC. | 453,686 | $8.3M | 0.2% |
| LRMR LARIMAR THERAPEUTICS INC | 1,500,000 | $6.8M | 0.1% |
| CYBIN INC | 1,313,137 | $6.3M | 0.1% |
| BLLN BILLIONTOONE INC | 50,000 | $3.9M | <0.1% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| MANE VERADERMICS INC | 500,000 | 2,000,000 | +300.0% | $245.9M |
| BMRN BIOMARIN PHARMACEUTICAL INC | 1,150,000 | 3,307,481 | +187.6% | $189.3M |
| CLDX CELLDEX THERAPEUTICS INC NEW | 1,283,979 | 2,939,151 | +128.9% | $109.4M |
| GMAB GENMAB A/S | 3,663,250 | 5,650,000 | +54.2% | $155.2M |
| NUVL NUVALENT INC | 1,376,324 | 1,783,322 | +29.6% | $220.2M |
| TNGX TANGO THERAPEUTICS INC | 2,750,000 | 4,200,000 | +52.7% | $131.3M |
| VIRIDIAN THERAPEUTICS INC | 1,393,944 | 3,592,740 | +157.7% | $66.0M |
| COGT COGENT BIOSCIENCES INC | 1,000,000 | 2,000,000 | +100.0% | $77.4M |
| NRIX NURIX THERAPEUTICS INC | 6,345,244 | 7,736,455 | +21.9% | $187.7M |
| GPCR STRUCTURE THERAPEUTICS INC | 4,279,848 | 4,740,072 | +10.8% | $254.4M |
| ALKS ALKERMES PLC | 3,590,323 | 4,000,000 | +11.4% | $209.6M |
| IONS IONIS PHARMACEUTICALS INC | 1,950,000 | 2,200,000 | +12.8% | $174.4M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| AXSM AXSOME THERAPEUTICS INC. | 1,100,000 | 700,000 | -36.4% | $171.3M |
| IMVT IMMUNOVANT INC | 11,526,971 | 9,341,151 | -19.0% | $359.9M |
| CYTK CYTOKINETICS INC | 1,374,320 | 700,000 | -49.1% | $59.6M |
| MBX MBX BIOSCIENCES INC | 2,757,569 | 1,732,569 | -37.2% | $95.6M |
| IMCR IMMUNOCORE HLDGS PLC | 1,931,884 | 311,218 | -83.9% | $9.9M |
| ALMS ALUMIS INC | 6,772,595 | 6,348,558 | -6.3% | $178.6M |
| DFTX DEFINIUM THERAPEUTICS INC | 3,000,000 | 2,750,000 | -8.3% | $129.4M |
| DYN DYNE THERAPEUTICS INC | 2,000,000 | 1,500,000 | -25.0% | $33.3M |
| ORKA ORUKA THERAPEUTICS INC | 2,034,203 | 1,926,000 | -5.3% | $183.3M |
| ENTA ENANTA PHARMACEUTICALS INC | 1,956,867 | 1,444,167 | -26.2% | $21.1M |
| KURA KURA ONCOLOGY INC | 2,643,542 | 1,978,565 | -25.2% | $21.7M |
| VERA VERA THERAPEUTICS INC | 4,106,067 | 4,000,000 | -2.6% | $171.6M |
CIK 1856083 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
